rs419788 — SKIV2L

Intronic SKIV2L variant in the MHC class III region; the T allele tags an independent susceptibility signal for systemic lupus erythematosus separate from HLA-DRB1

See your personal result for SKIV2L

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SKIV2L rs419788 — An MHC Class III Brake on Autoimmunity

The major histocompatibility complex (MHC) on chromosome 6 is the most gene-dense immune region in the human genome, and its class III segment — wedged between the complement genes and the classical HLA loci — contains a cluster of RNA surveillance genes that few people know about. One of them, SKIV2L (Superkiller Viralicidic Activity 2-Like), encodes the RNA helicase at the heart of the cytoplasmic RNA exosome. rs419788 is an intronic variant within SKIV2L that marks an independent genetic susceptibility signal for systemic lupus erythematosus11 independent genetic susceptibility signal for systemic lupus erythematosus
Fernando et al. 2007: family-based study of 314 UK SLE trios; rs419788-T allele OR 2.0, p=4.3×10⁻⁸; independent of HLA-DRB1*0301 by conditional analysis (SLE) — one that is completely separate from the HLA-DRB1 risk alleles that most people associate with lupus genetics.

The Mechanism

SKIV2L is the engine of the SKI complex, an evolutionarily ancient RNA surveillance machine. Its job is to unwind damaged, misfolded, and viral RNA substrates and feed them into the cytoplasmic RNA exosome for 3'→5' degradation. In the context of innate immunity, this has a crucial regulatory function: when the OAS-RNase L pathway detects viral double-stranded RNA, RNase L cleaves cellular and viral RNA into short fragments that can then re-trigger RIG-I-like receptor (RLR) signaling — amplifying the interferon response. SKIV2L acts as a brake on this amplification loop: it degrades RNase L-processed RNA fragments22 degrades RNase L-processed RNA fragments
Yang et al. 2024 EMBO J: SKIV2L-deficient cells show markedly elevated IFN responses to RNase L-processed RNA; helicase activity is required; SKIV2L loss exacerbates autoinflammation from OAS1 gain-of-function mutations before they can drive further interferon production.

A second, more recently described function connects SKIV2L directly to the B cell arm of autoimmunity. Conditional knockout of Skiv2l in B cell precursors33 Conditional knockout of Skiv2l in B cell precursors
Science Immunology 2022; Skiv2l-deficient pro-B cells show cell cycle arrest, DNA damage, and failed V(D)J rearrangement of immunoglobulin heavy chain; mice lack both conventional B-2 and innate-like B-1 B cells causes a complete block at the pro-B to pre-B transition. Without SKIV2L-mediated RNA surveillance, pro-B cells accumulate aberrant RNA species that trigger DNA damage signaling and arrest development — the same pro-B stage where autoreactive B cell clones are normally selected against. Disrupted RNA quality control at this checkpoint may allow autoreactive precursors to escape normal negative selection.

rs419788 lies in intron 6 of SKIV2L. It does not change the protein sequence but likely affects regulatory elements or splicing efficiency, potentially altering SKIV2L expression in immune cell subsets. The exact functional consequence of the T allele on SKIV2L transcription or protein levels has not been published, but the association data are consistent with reduced or dysregulated SKIV2L activity weakening the brake on RLR signaling and B cell RNA surveillance.

The Evidence

The primary association was established by Fernando et al. in 200744 Fernando et al. in 2007
PLoS Genetics; 314 complete UK Caucasian SLE trios; TDT-based family analysis; rs419788-T OR 2.0 (95% CI 1.6–2.6), nominal p=4.3×10⁻⁸, permuted p<0.0001; two independent MHC signals (DRB1*0301 and rs419788-T) confirmed by conditional analysis in a family-based study of 314 UK SLE trios. The analysis used transmission disequilibrium testing — a design that is robust to population stratification, a serious confounder in MHC studies — and demonstrated that the SKIV2L class III signal and the HLA-DRB1*0301 class II signal are genetically independent: only 47% of rs419788-T haplotypes carry DRB1*0301. This means the two alleles act additively; carriers of both face the highest combined MHC risk.

A subsequent high-density MHC screen55 high-density MHC screen
Barcellos et al. 2009 PLoS Genetics; 1,610 SLE cases and 1,470 controls; 1,974 MHC SNPs plus HLA-DRB1; SKIV2L SNPs including rs419788 showed p<0.01 in single-marker analysis but did not survive conditional haplotype method at p<0.01 threshold in 1,610 SLE cases confirmed that the SKIV2L locus harbours association signal, but rs419788 specifically did not survive the more stringent conditional analysis at that study's threshold. This pattern is consistent with rs419788 being a tagging SNP in moderate LD with a broader class III susceptibility haplotype spanning SKIV2L, STK19, and CFB, rather than the causal variant itself. The evidence level is therefore rated moderate: the association is well-replicated at the regional level, but the index SNP signal requires further fine-mapping to determine the causal variant.

SKIV2L sits between complement factor B (CFB) and STK19 — both of which also carry SLE associations. Disentangling the contribution of SKIV2L variants from complement pathway variants in this region remains an active area of research.

Practical Actions

For CT heterozygotes and TT homozygotes, the actionable implications center on SLE surveillance. The T allele marks elevated risk for an autoimmune disease defined by loss of self-tolerance, immune complex deposition, and organ damage — kidney, brain, and skin being the most common targets. Familial history of lupus, Sjögren's syndrome, or other connective tissue diseases in combination with this genotype warrants heightened vigilance. For TT homozygotes the risk is materially elevated and proactive autoantibody screening is appropriate.

The SKIV2L pathway also intersects with innate immune activation triggered by endogenous retroviruses and viral RNA — UV radiation and viral infections (Epstein-Barr virus in particular) are among the most potent known triggers of lupus flares. UV-induced keratinocyte apoptosis releases nuclear antigens that drive the autoantibody cascade; minimizing this exposure is genotype-relevant advice, not generic skin-care guidance.

Interactions

rs419788 (SKIV2L) marks a class III MHC signal that is independent of and additive to the class II signal at HLA-DRB1*0301 (rs2187668 rs7454108 in LD). The rs7574865 (STAT4) T allele acts through an entirely different pathway — amplified interferon-alpha and IL-12 signaling downstream of JAK-STAT — and its effects are also additive with MHC class III risk. Carriers of rs419788-T (SKIV2L risk), rs7574865-T (STAT4 risk), and HLA-DRB1 risk alleles face a substantially elevated composite genetic burden for SLE. The complement-pathway variant rs1270942 (CFB) in the same chromosomal neighbourhood further stratifies risk for immune complex-mediated nephritis; because CFB and SKIV2L are in partial LD, they should be interpreted together rather than as fully independent signals.

Genotype Interpretations

What each possible genotype means for this variant.

CC Low-Risk Genotype Normal

Common SKIV2L genotype; no elevated risk for SLE from this variant

You carry two copies of the common C allele at rs419788. The T allele that tags the SKIV2L-associated SLE susceptibility signal in this region is absent, so this particular MHC class III locus does not contribute elevated lupus risk. This genotype is found in approximately 47% of people of European descent (and is even more common in African-ancestry populations, at over 80%). Your SLE risk from this variant is at population baseline.

CT Elevated SLE Risk Intermediate

One T allele doubles the risk of carrying the SKIV2L-associated SLE susceptibility signal

You carry one copy of the T allele at rs419788. This allele marks an independent class III MHC susceptibility signal for systemic lupus erythematosus, with an odds ratio of approximately 2.0 per T allele in additive fashion. Heterozygous CT individuals carry approximately one copy of this risk signal, translating to a roughly 70–90% elevated relative risk for SLE compared to CC homozygotes — a real but moderate increase. About 43% of European-ancestry individuals carry this CT genotype. The risk is additive with other lupus risk loci, including HLA-DRB1 and STAT4; if you also carry risk alleles at those loci, your composite genetic risk is higher than any single variant suggests.

TT High-Risk SKIV2L Genotype High Risk

Two T alleles confer the highest SKIV2L-associated SLE risk and warrant proactive autoantibody screening

You carry two copies of the T allele — the highest-risk genotype at this locus. Homozygous TT individuals carry two doses of the SKIV2L-associated MHC class III susceptibility signal for systemic lupus erythematosus. Assuming additive inheritance (as demonstrated in the 2007 Fernando et al. study), TT homozygosity corresponds to roughly a fourfold elevated SLE risk relative to CC, though precise TT-specific OR estimates in replication cohorts have not been published. About 10% of European-ancestry individuals carry this genotype (rare in African-ancestry populations at under 1%). Combined with other lupus genetic risk factors — HLA-DRB1 risk alleles, STAT4 rs7574865-T, IRF5 variants — TT homozygosity can place an individual in a high cumulative genetic risk tier warranting proactive clinical evaluation.